menu search

Amazon ceo andy jassy says the company's injury rate is 'misunderstood.' we found it's higher than he says

In his first shareholder letter, Amazon CEO Andy Jassy used misleading statistics to claim that Amazon's injur...

April 14, 2022, 3:27 pm

Amazon ceo jassy says he wants to improve warehouse safety

In his first letter to Amazon shareholders, CEO Andy Jassy offered a defense of wages and benefits the company gives its warehouse workers while also ...

April 14, 2022, 10:40 am

Amazon's injury rate jumped 20% last year, new report shows

injury rates at Amazon warehouses increased about 20% over the last year, according to a new analysis o...

April 12, 2022, 5:05 pm

Windtree posts mid-stage study data on lucinactant for covid-19-associated respiratory distress

Windtree Therapeutics Inc (NASDAQ: WINT) announced results from its Phase 2 study of lucinactant (KL4 surfactant) for severe COVID-19 associated ac...

March 22, 2022, 1:50 pm

Plx pharma inc. to present at oppenheimer & co's 32nd annual healthcare conference on march 15, 2022

SPARTA, N.J., March 01, 2022 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”) is a commercial-stage drug delivery ...

March 1, 2022, 6:50 am

Plx pharma inc. to present at oppenheimer & co's 32nd annual healthcare conference on march 15, 2022

SPARTA, N.J., March 01, 2022 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”) is a commercial-stage drug delivery ...

March 1, 2022, 6:50 am

Plx pharma inc. to present at oppenheimer & co's 32nd annual healthcare conference on march 15, 2022

SPARTA, N.J., March 01, 2022 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”) is a commercial-stage drug delivery ...

March 1, 2022, 6:50 am

Revive therapeutics receives orphan drug designation for bucillamine in the prevention of ischemia-reperfusion injury during liver transplantation

Revive Therapeutics Ltd (CSE:RVV, OTCQB:RVVTF) announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for ...

February 16, 2022, 7:30 am

Revive therapeutics receives orphan drug designation for bucillamine in the prevention of ischemia-reperfusion injury during liver transplantation

Revive Therapeutics Ltd (CSE:RVV, OTCQB:RVVTF) announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for ...

February 16, 2022, 7:30 am

Revive therapeutics receives orphan drug designation for bucillamine in the prevention of ischemia-reperfusion injury during liver transplantation

Revive Therapeutics Ltd (CSE:RVV, OTCQB:RVVTF) announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for ...

February 16, 2022, 7:30 am

Why are windtree therapeutics shares trading higher today?

Windtree Therapeutics Inc WINT has completed enrollment in its Phase 2 study of lucinactant for COVID-19 associated lung ...

February 1, 2022, 2:36 pm

Why are windtree therapeutics shares trading higher today?

Windtree Therapeutics Inc WINT has completed enrollment in its Phase 2 study of lucinactant for COVID-19 associated lung ...

February 1, 2022, 2:36 pm

Why are windtree therapeutics shares trading higher today?

Windtree Therapeutics Inc WINT has completed enrollment in its Phase 2 study of lucinactant for COVID-19 associated lung ...

February 1, 2022, 2:36 pm

U.s. physical therapy, inc. schedules fourth quarter and year ended 2021 earnings release and conference call for thursday, february 24, 2022

HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industr...

January 24, 2022, 11:00 am

U.s. physical therapy, inc. schedules fourth quarter and year ended 2021 earnings release and conference call for thursday, february 24, 2022

HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industr...

January 24, 2022, 11:00 am

U.s. physical therapy, inc. schedules fourth quarter and year ended 2021 earnings release and conference call for thursday, february 24, 2022

HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industr...

January 24, 2022, 11:00 am

Axsome therapeutics: expect victory in 2022

Amid the 2021 Biotech Bear market, most bio-stocks are trading at a deep bargain to their intrinsic value.Adding insult to ...

January 1, 2022, 10:21 am

Axsome therapeutics: expect victory in 2022

Amid the 2021 Biotech Bear market, most bio-stocks are trading at a deep bargain to their intrinsic value.Adding insult to ...

January 1, 2022, 10:21 am

Axsome therapeutics: expect victory in 2022

Amid the 2021 Biotech Bear market, most bio-stocks are trading at a deep bargain to their intrinsic value.Adding insult to ...

January 1, 2022, 10:21 am

Angion (angn) kidney drug misses third study goal in 2021

Angion's (ANGN) phase II study evaluating ANG-3777 in cardiac surgery-associated acute kidney injury fa...

December 13, 2021, 1:50 pm


Search within

Pages Search Results: